PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s diseasePreston Ge, Ted M. Dawson|Molecular Neurodegeneration|2020Cited by 484
Meta‐analysis of Parkinson's Disease: Identification of a novel locus, <i>RIT2</i>Nathan Pankratz, Tatiana Foroud, Gary W. Beecham et al.|Annals of Neurology|2011Cited by 299
Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stressDarren J. Moore, Valina L. Dawson, Li Zhang et al.|Human Molecular Genetics|2004Cited by 247
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, Valérie C. Besson et al.|British Journal of Pharmacology|2017Cited by 210
<i>Bcl-x</i>Is Required for Proper Development of the Mouse Substantia NigraJoseph M. Savitt, Ted M. Dawson|Journal of Neuroscience|2005Cited by 178